| FDA Enforcement Basics: 483 to Consent Decree |
Regulatory Affairs Professional Society Annual Conference |
2004 |
| Understanding FDA's Regulation of Combination Drugs |
Center for Business Intelligence |
2004 |
| Understanding FDA's Regulation of Combination Drugs |
Barnett International Conference Group |
2004 |
| Managing Clinical Research in the Post-HIPAA World: The privacy rule will permanently alter the dynamics of relationships among sponsors, investigator, IRBs, and human subjects |
MX - Business Strategies for Medical Technology Executives |
2003 |
| Association of Clinical Research Professionals |
Fraud & Noncompliance |
2003 |
| Managing the Oversight of Phase IV Clinical Trials: What Is the IRB's Responsibility? |
Barnett International Conference Group |
2003 |
| Legal & Regulatory Insights on Privacy Protection and HIPAA Compliance in Phase IV Clinical Trials |
Center for Business Intelligence |
2002 |